• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human BTB/POZ domain-containing protein 9 (BTBD9)

ACP13155

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP13155 Target NameBTBD9
Target SynonymsBTB/POZ domain-containing protein 9; Btbd9; BTBD9_HUMANFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-612
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ96Q07
Background Information
  • Uniprot Id

    Q96Q07

  • Target Species

    Human

  • Target Name

    BTBD9

  • Target Full Name

    BTB/POZ domain-containing protein 9

  • Target Involvement

    Restless legs syndrome 6 (RLS6)

  • Target Tissue Specificity

    Detected in the brain (at protein level). Moderately expressed in all specific brain regions examined. Expressed in the dopaminergic neurons of the substantia nigra and A11 neurons. Highly expressed in kidney and moderately expressed in all other adult an

  • Target Synonyms

    BTB/POZ domain-containing protein 9; Btbd9; BTBD9_HUMAN

  • Target Background

    This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome. Alternatively spliced transcript variants have been described.

Inquire Recombinant Human BTB/POZ domain-containing protein 9 (BTBD9) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification